Related Experiment Video

Updated: Feb 5, 2026

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.7K

Rituximab (anti-CD20)-modified AZD-2014-encapsulated nanoparticles killing of B lymphoma cells

Xiaolong Tang1, Chunmei Xie2, Zhenyou Jiang3

  • 1a Medical College , Anhui University of Science and Technology , Huainan , China.

Artificial Cells, Nanomedicine, and Biotechnology
|September 11, 2018
PubMed

Insights

This study developed targeted nanoparticles carrying an mTOR inhibitor, AZD-2014, for B-cell non-Hodgkin's lymphoma (NHL). The novel drug delivery system effectively inhibited NHL cell growth and promoted apoptosis, showing promise for NHL therapy.

Area of Science:

  • Oncology
  • Nanomedicine
  • Molecular Biology

Background:

  • The mTOR signaling pathway is frequently overactive in B-cell non-Hodgkin's lymphoma (NHL), contributing to cancer progression and resistance to chemotherapy.
  • Targeting the mTOR pathway presents a promising strategy for developing novel therapeutic agents against NHL.

Purpose of the Study:

  • To develop and evaluate the efficacy of rituximab-modified, nanoparticle-encapsulated mTOR inhibitor (Ab-NPs-AZD-2014) against B-cell non-Hodgkin's lymphoma (NHL).

Main Methods:

  • Development of Ab-NPs-AZD-2014, a drug delivery system combining rituximab (anti-CD20) with the mTOR inhibitor AZD-2014 encapsulated in nanoparticles.
  • In vitro assessment of Ab-NPs-AZD-2014's effects on NHL cell lines, including cell growth inhibition, apoptosis induction, and mTORC1/mTORC2 signaling blockade.

Main Results:

  • Ab-NPs-AZD-2014 demonstrated significant inhibition of NHL cancer cell growth in vitro.
  • The targeted nanoparticles successfully induced apoptosis in NHL cells.
  • Treatment with Ab-NPs-AZD-2014 effectively blocked the activation of both mTORC1 and mTORC2 signaling pathways in Raji cells.

Conclusions:

  • Antibody modification and nanomaterial loading of AZD-2014 with anti-CD20 significantly enhanced its efficacy against NHL cells.
  • The Ab-NPs-AZD-2014 approach shows potential as a therapeutic strategy for non-Hodgkin's lymphoma and warrants further clinical investigation.
Keywords:
AZD-2014Non-Hodgkin’s lymphomaTOR serine-threonine kinasesmTORnanoparticlesrituximabsignal pathways

More Related Videos

Flash NanoPrecipitation for the Encapsulation of Hydrophobic and Hydrophilic Compounds in Polymeric Nanoparticles10:12

Flash NanoPrecipitation for the Encapsulation of Hydrophobic and Hydrophilic Compounds in Polymeric Nanoparticles

Published on: January 7, 2019

23.6K
Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma08:53

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Published on: June 10, 2017

10.5K

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.8K
Modified Boxplots00:57

Modified Boxplots

A standard box and whisker plot informs us about the spread of the data in a given sample. One can identify the minimum value, maximum value, first quartile value, second quartile or median value, and third quartile.
However, the box plot does not tell the reader about outliers - values that lie far from the center of the data. We can modify the standard box and whisker plot to identify the outliers and visualize the actual spread of the data in a sample.
Initially, we calculate the adjusted...
11.2K
Waterproofing and Anti-Bacterial Admixtures in Concrete01:22

Waterproofing and Anti-Bacterial Admixtures in Concrete

Concrete's susceptibility to water absorption is due to the capillary action within the pores of its hydrated cement paste. This action draws water in, creating the need for waterproofing admixtures to prevent such penetration. The efficacy of these admixtures is contingent upon the water pressure, with variations arising from different conditions such as rain, capillary rise, or hydrostatic pressure in structures intended to hold water.
Waterproofing admixtures render concrete hydrophobic,...
244
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
1.9K
Oxidation of Alkenes: Anti Dihydroxylation with Peroxy Acids02:04

Oxidation of Alkenes: Anti Dihydroxylation with Peroxy Acids

Diols are compounds with two hydroxyl groups. In addition to syn dihydroxylation, diols can also be synthesized through the process of anti dihydroxylation. The process involves treating an alkene with a peroxycarboxylic acid to form an epoxide. Epoxides are highly strained three-membered rings with oxygen and two carbons occupying the corners of an equilateral triangle. This step is followed by ring-opening of the epoxide in the presence of an aqueous acid to give a trans diol.
7.4K
Radical Anti-Markovnikov Addition to Alkenes: Overview01:25

Radical Anti-Markovnikov Addition to Alkenes: Overview

The addition of hydrogen bromide to alkenes in the presence of hydroperoxides or peroxides proceeds via an anti-Markovnikov pathway and yields alkyl bromides.
4.3K